Concentrix Analysts Slash Their Forecasts After Downbeat Q2 Results

Benzinga06-30 22:45

Concentrix Corp (NASDAQ:CNXC) on Monday reported worse-than-expected second-quarter financial results and cut its FY26 guidance below estimates.

Concentrix reported quarterly earnings of $2.63 per share, which missed the analyst consensus estimate of $2.64, according to Benzinga Pro data. Quarterly revenue came in at $2.46 billion, which missed the consensus estimate of $2.47 billion by 0.44%.

"Our second quarter marked an acceleration in many areas in the evolution of our business," said Chris Caldwell, CEO of Concentrix.

Concentrix lowered its fiscal 2026 adjusted EPS guidance to between $10.83 and $11.18, versus the $11.97 analyst estimate, and lowered its revenue outlook to $9.93 billion to $10.03 billion, versus the $10.14 billion estimate.

Concentrix shares dipped 18.2% to trade at $20.64 on Tuesday.

These analysts made changes to their price targets on Concentrix following earnings announcement.

Baird analyst David Koning maintained the stock with an Outperform rating and lowered the price target from $40 to $30.
Barrington Research analyst Vincent Colicchio maintained the stock with an Outperform rating and lowered the price target from $38 to $30.

Considering buying CNXC stock? Here’s what analysts think:

Photo via Shutterstock

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2647838557?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-30 22:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2647838557","market":"us","top_or_hot":-1,"title":"Concentrix Analysts Slash Their Forecasts After Downbeat Q2 Results","media":"Benzinga","content":"<html><body><p><strong><a href=\"https://laohu8.com/S/CNXC\">Concentrix Corp</a> </strong>(NASDAQ:CNXC) on Monday reported worse-than-expected second-quarter financial results and cut its FY26 guidance below estimates.</p>\n<p>Concentrix reported quarterly earnings of $2.63 per share, which missed the analyst consensus estimate of $2.64, according to Benzinga Pro data. Quarterly revenue came in at $2.46 billion, which missed the consensus estimate of $2.47 billion by 0.44%.</p>\n<p>\"Our second quarter marked an acceleration in many areas in the evolution of our business,\" said Chris Caldwell, CEO of Concentrix.</p>\n<p>Concentrix lowered its fiscal 2026 adjusted EPS guidance to between $10.83 and $11.18, versus the $11.97 analyst estimate, and lowered its revenue outlook to $9.93 billion to $10.03 billion, versus the $10.14 billion estimate.</p>\n<p>Concentrix shares dipped 18.2% to trade at $20.64 on Tuesday.</p>\n<p>These analysts made changes to their price targets on Concentrix following earnings announcement.</p>\n<ul>\n<li>Baird analyst David Koning maintained the stock with an Outperform rating and lowered the price target from $40 to $30.</li>\n<li>Barrington Research analyst Vincent Colicchio maintained the stock with an Outperform rating and lowered the price target from $38 to $30.</li>\n</ul>\n<p><strong>Considering buying CNXC stock? Here’s what analysts think:</strong></p>\n<figure><img decoding=\"async\" height=\"483\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/06/30104453/image-833-1024x483.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/06/30104453/image-833-1024x483.png 1024w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/06/30104453/image-833-300x141.png 300w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/06/30104453/image-833-768x362.png 768w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/06/30104453/image-833.png 1192w\" width=\"1024\"/></figure>\n<p><em>Photo via Shutterstock</em></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Concentrix Analysts Slash Their Forecasts After Downbeat Q2 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nConcentrix Analysts Slash Their Forecasts After Downbeat Q2 Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2026-06-30 22:45</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p><strong><a href=\"https://laohu8.com/S/CNXC\">Concentrix Corp</a> </strong>(NASDAQ:CNXC) on Monday reported worse-than-expected second-quarter financial results and cut its FY26 guidance below estimates.</p>\n<p>Concentrix reported quarterly earnings of $2.63 per share, which missed the analyst consensus estimate of $2.64, according to Benzinga Pro data. Quarterly revenue came in at $2.46 billion, which missed the consensus estimate of $2.47 billion by 0.44%.</p>\n<p>\"Our second quarter marked an acceleration in many areas in the evolution of our business,\" said Chris Caldwell, CEO of Concentrix.</p>\n<p>Concentrix lowered its fiscal 2026 adjusted EPS guidance to between $10.83 and $11.18, versus the $11.97 analyst estimate, and lowered its revenue outlook to $9.93 billion to $10.03 billion, versus the $10.14 billion estimate.</p>\n<p>Concentrix shares dipped 18.2% to trade at $20.64 on Tuesday.</p>\n<p>These analysts made changes to their price targets on Concentrix following earnings announcement.</p>\n<ul>\n<li>Baird analyst David Koning maintained the stock with an Outperform rating and lowered the price target from $40 to $30.</li>\n<li>Barrington Research analyst Vincent Colicchio maintained the stock with an Outperform rating and lowered the price target from $38 to $30.</li>\n</ul>\n<p><strong>Considering buying CNXC stock? Here’s what analysts think:</strong></p>\n<figure><img decoding=\"async\" height=\"483\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/06/30104453/image-833-1024x483.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/06/30104453/image-833-1024x483.png 1024w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/06/30104453/image-833-300x141.png 300w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/06/30104453/image-833-768x362.png 768w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/06/30104453/image-833.png 1192w\" width=\"1024\"/></figure>\n<p><em>Photo via Shutterstock</em></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CNXC","symbol_name":"Concentrix Corp","start_time":0,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/06/60189980/concentrix-analysts-slash-their-forecasts-after-downbeat-q2-results","article_id":"2647838557","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2647838557","pubTimestamp":1782830756,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":"Concentrix (CNXC) reports lower-than-expected Q2 earnings and cuts FY26 guidance. Analysts lower price targets. Stock falls 18.2% to $20.64.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CNXC":"Concentrix Corp","BK4106":"数据处理与外包服务","LU2065170008.USD":"M&G (LUX) GLOBAL MAXIMA \"A\" (USD) INC","BK4226":"数据处理及外包服务","LU2065171311.SGD":"M&G (LUX) GLOBAL MAXIMA \"A\" (SGD) ACC","LU2065169927.USD":"M&G (LUX) GLOBAL MAXIMA \"A\" (USD) ACC","LU2065171402.SGD":"M&G (LUX) GLOBAL MAXIMA \"A\" (SGD) INC"},"translate_title":"Concentrix分析师在第二季度业绩悲观后大幅下调预测","themeId":"11c8fbbf839f433c9d274cef5f173382","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CNXC":1},"content_text":"Concentrix Corp (NASDAQ:CNXC) on Monday reported worse-than-expected second-quarter financial results and cut its FY26 guidance below estimates.\nConcentrix reported quarterly earnings of $2.63 per share, which missed the analyst consensus estimate of $2.64, according to Benzinga Pro data. Quarterly revenue came in at $2.46 billion, which missed the consensus estimate of $2.47 billion by 0.44%.\n\"Our second quarter marked an acceleration in many areas in the evolution of our business,\" said Chris Caldwell, CEO of Concentrix.\nConcentrix lowered its fiscal 2026 adjusted EPS guidance to between $10.83 and $11.18, versus the $11.97 analyst estimate, and lowered its revenue outlook to $9.93 billion to $10.03 billion, versus the $10.14 billion estimate.\nConcentrix shares dipped 18.2% to trade at $20.64 on Tuesday.\nThese analysts made changes to their price targets on Concentrix following earnings announcement.\n\nBaird analyst David Koning maintained the stock with an Outperform rating and lowered the price target from $40 to $30.\nBarrington Research analyst Vincent Colicchio maintained the stock with an Outperform rating and lowered the price target from $38 to $30.\n\nConsidering buying CNXC stock? Here’s what analysts think:\n\nPhoto via Shutterstock","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"express","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2647838557","isCrawlerRequest":true}